Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?

Authors

Sandra Korol, University of Montreal
Michel White, Institut de Cardiologie de Montreal
Eileen O’Meara, Institut de Cardiologie de Montreal
Jean Lucien Rouleau, Institut de Cardiologie de Montreal
Brian White-Guay, University of Montreal
Marc Dorais, Sanofi Aventis Endowment Research Chair in Optimal Drug Use
Ali Ahmed, Washington DC VA Medical Center
Simon de Denus, University of Montreal
Sylvie Perreault, University of Montreal

Document Type

Journal Article

Publication Date

1-1-2019

Journal

European Journal of Clinical Pharmacology

DOI

10.1007/s00228-018-02615-8

Keywords

Aldosterone; Diabetes mellitus; Heart failure; Mineralocorticoid receptor; Spironolactone

APA Citation

Korol, S., White, M., O’Meara, E., Rouleau, J., White-Guay, B., Dorais, M., Ahmed, A., de Denus, S., & Perreault, S. (2019). Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?. European Journal of Clinical Pharmacology, (). http://dx.doi.org/10.1007/s00228-018-02615-8